Cagrilintide Dosage & Reconstitution Calculator
Enter the vial mass and your bacteriostatic-water volume; read the concentration and the exact U-100 syringe units for Cagrilintide — drawn to scale. A long-acting amylin analog developed for obesity and type 2 diabetes, designed for once-weekly subcutaneous dosing with a half-life exceeding one week. NHOV Cagrilintide is released against a ≥99% HPLC specification with a Certificate of Analysis on every batch.
One band is one complete draw. The highlighted band is the draw shown on the barrel.
Awaiting vial mass, solvent volume, and mass per draw.
Figures describe the contents of a vial and the graduation they measure to. Supplied for laboratory research use only. Not a dosing protocol and not medical advice.
Cagrilintide at a glance
| Molecular weight | 4409.01 g/mol |
|---|---|
| CAS number | 1415456-99-3 |
| Reported half-life | 184 ± 7.4 hours (~7.7 days) |
| Administration route (research) | Subcutaneous injection |
| Purity specification | ≥99%, with mass-spec identity confirmation |
| Documentation | Lot-specific Certificate of Analysis per batch |
| Physical form | Lyophilised powder — reconstitute before laboratory use |
How to reconstitute Cagrilintide
Enter the vial
Type the labelled peptide mass in milligrams and your bacteriostatic-water volume into the tool above. Concentration and the per-unit draw update live.
Add the solvent
Run the water slowly down the inside glass wall — never onto the powder directly. Swirl gently until fully dissolved; do not shake.
Read & store
Draw the exact U-100 units the tool prints for your target mass. Store the reconstituted vial at 2–8 °C, protected from light.
Order Cagrilintide
≥99% HPLC · mass-spec identity · Certificate of Analysis on every batch · cold-chain dispatch.